Infectious agent
|
No. of samples testeda
|
No. positive (%)
|
---|
HBsAg
|
162
|
32 (19.8)
|
HEVb
|
198
|
27 (13.6)
|
HCVAg
|
162
|
9 (5.6)
|
P. falciparum
|
198
|
4 (2.0)
|
Anti-HDc
|
50
|
17 (34.0)
|
HEV + HBsAg
|
162
|
6 (3.7)
|
HBsAg + HCVAg
|
162
|
4 (2.5)
|
HBsAg + P. falciparum
|
162
|
4 (2.5)
|
P. falciparum + HCVAg
|
162
|
3 (1.9)
|
HCVAg + HEV
|
162
|
2 (1.2)
|
HEV + P. falciparum
|
198
|
2 (1.0)
|
HBsAg + HEV + P. falciparum
|
162
|
2 (1.2)
|
HBsAg + HEV + HCVAg
|
162
|
1 (0.6)
|
HBSAg + P. falciparum + HCVAg
|
162
|
1 (0.6)
|
Other pathogensd
|
198
|
0 (0,0)
|
-
aAfter testing sera for leptospirosis; dengue arbovirus; chikungunya, Zika, Crimean–Congo haemorrhagic fever, West Nile and Rift Valley viruses; and P. falciparum, sufficient quantities of serum remained for testing only a further 162 samples
-
bHepatitis E virus, tested with qPCR
-
cHepatitis delta virus
-
dLeptospirosis; DENV; CHIK, ZIKV, CCHFV, WNV and RVFV